SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-177154
Filing Date
2021-05-28
Accepted
2021-05-28 16:58:38
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d570660ds3.htm S-3 410152
2 EX-5.1 d570660dex51.htm EX-5.1 19574
3 EX-23.1 d570660dex231.htm EX-23.1 1749
4 EX-23.2 d570660dex232.htm EX-23.2 1717
5 GRAPHIC g570660g12s86.jpg GRAPHIC 48894
  Complete submission text file 0001193125-21-177154.txt   497751
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256647 | Film No.: 21981330
SIC: 2834 Pharmaceutical Preparations